Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 20:38 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,500 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001683168-26-005111 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-06-22 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:35 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,500 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001683168-26-005109 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-06-22 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 20:35 UTC |
Lemerond NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 44,500 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001683168-26-005110 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-06-22 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 17:03 UTC |
IWAKI YUICHIPresident and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001683168-26-000428 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2035-01-06 F1 · balance_after: On January 7, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 22:04 UTC |
Matsuda KazukoChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001683168-26-000430 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2035-01-06 F1 · balance_after: On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:11 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001683168-25-004651 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-06-16 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2025, December 31, 2025, March 31, 2026 and June 30,2026, subject to continued service with the Company. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:11 UTC |
Lemerond NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001683168-25-004649 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-06-16 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2025, December 31,2025, March 31,2026 and June 30,2026, subject to continued service with the Company. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:10 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001683168-25-004648 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-06-16 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026, subject to continued service with the Company. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 16:50 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001044 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:54 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,500 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001051 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:52 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001049 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests over a period of one year in equal monthly installments from the 2/12/2025 date of grant. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:51 UTC |
Lemerond NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,500 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001046 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12,2025 and February 12, 2026, subject to continued service with the Company. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:49 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,500 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001683168-25-001042 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2035-02-11 F1 · derivative.exercise_date: The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:00 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001683168-25-000218 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-01-17 F1 · balance_after: On January 18, 2024, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Such performance criteria for 2024 were met, resulting in full vesting of the option. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:00 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001683168-25-000217 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-01-17 F1 · balance_after: On January 18, 2024, the reporting person was granted an option to purchase 300,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Such performance criteria for 2024 were met, resulting in full vesting of the option. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 23:41 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001683168-24-004156 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-10 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 23:40 UTC |
Lemerond NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001683168-24-004155 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-10 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 23:40 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001683168-24-004154 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-10 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 16:51 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 210,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001683168-24-000221 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2033-01-31 F1 · balance_after: On February 1, 2023, the reporting person was granted an option to purchase 300,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 210,000 shares. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:52 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001683168-24-000225 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2033-01-31 F1 · balance_after: On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:52 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 157,500 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001683168-24-000223 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,500 Underlying: Common Stock · 157,500 shares Expires 2033-01-31 F1 · balance_after: On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:18 UTC |
Lemerond NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,333 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001683168-23-005416 · ownership.xml · derivative · entry 1 Lemerond Nicole · CIK 0001941712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,333 Underlying: Common Stock · 18,333 shares Expires 2033-08-03 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 22:03 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0001683168-23-004189 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 22:03 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0001683168-23-004188 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:19 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 235,125 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001683168-23-000345 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,125 Underlying: Common Stock · 235,125 shares Expires 2032-01-26 F1 · balance_after: On January 27, 2022, the reporting person was granted an option to purchase 247,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 235,125 shares. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:17 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 76,950 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001683168-23-000343 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,950 Underlying: Common Stock · 76,950 shares Expires 2032-01-26 F1 · balance_after: On January 27, 2022 the reporting person was granted an option to purchase 81,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 76,950 shares. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:16 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 149,625 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001683168-23-000341 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,625 Underlying: Common Stock · 149,625 shares Expires 2032-01-26 F1 · balance_after: On January 27, 2022, the reporting person was granted an option to purchase 157,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 149,625 shares. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 22:23 UTC |
Nagao HidekiDirector
|
SaleCommon Stock | 6,754 | $2.25 | $15,196.50 |
DisclosureSEC source: 0001683168-22-008111 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:01 UTC |
Nagao HidekiDirector
|
SaleCommon Stock | 218 | $2.13 | $464.34 |
DisclosureSEC source: 0001683168-22-008020 · ownership.xml · nonDerivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,754 Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:01 UTC |
Nagao HidekiDirector
|
SaleCommon Stock | 5,365 | $2.18 | $11,695.70 |
DisclosureSEC source: 0001683168-22-008020 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,972 Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:35 UTC |
Nagao HidekiDirector
|
SaleCommon Stock | 309 | $2.18 | $673.62 |
DisclosureSEC source: 0001683168-22-007952 · ownership.xml · nonDerivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,337 Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:23 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0001683168-22-004429 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 21:22 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0001683168-22-004428 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023, subject to continued service with the Company. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:00 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 302,500 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001683168-22-000594 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,500 Underlying: Common Stock · 302,500 shares Expires 2031-02-17 F1 · balance_after: On February 18, 2021, the reporting person was granted an option to purchase 550,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 302,500 shares. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 02:01 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001683168-22-000596 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2031-02-17 F1 · balance_after: On February 18, 2021, the reporting person was granted an option to purchase 180,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 99,000 shares. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 02:00 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 192,500 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001683168-22-000595 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,500 Underlying: Common Stock · 192,500 shares Expires 2031-02-17 F1 · balance_after: On February 18, 2021, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 192,500 shares. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 11:52 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001683168-21-003893 · ownership.xml · derivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 9/1/2011 date of grant and is now fully vested. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 11:52 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 60,000 | $2.30 | $138,000.00 |
DisclosureSEC source: 0001683168-21-003893 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2021 Filed Jul 23, 2021 16:27 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionEmployee Stock option (Right to Buy) · Derivative | 39,583 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-21-003082 · ownership.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,583 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| July 09, 2021 Filed Jul 23, 2021 16:27 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionCommon Stock | 39,583 | $2.54 | $100,540.82 |
DisclosureSEC source: 0001683168-21-003082 · ownership.xml · nonDerivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 56,250 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · derivative · entry 4 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,250 shares Expires 2021-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 46,554 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · derivative · entry 3 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,554 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 56,250 | $2.46 | $138,375.00 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · nonDerivative · entry 2 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 20:50 UTC |
Matsuda KazukoDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 46,554 | $2.54 | $118,247.16 |
DisclosureSEC source: 0001683168-21-002744 · ownership.xml · nonDerivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 19:47 UTC |
BEAVER CAROLYNDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001683168-21-002631 · ownership.xml · derivative · entry 1 BEAVER CAROLYN · CIK 0001335581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2021, December 31, 2021, March 31, 2022 and June 30, 2022, subject to continued service with the Company. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 19:48 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001683168-21-002633 · ownership.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2021, December 31, 2021, March 31, 2022 and June 30, 2022, subject to continued service with the Company. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC |
OBrien GeoffreyVice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,318 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · derivative · entry 4 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 Underlying: Common Stock · 11,318 shares Expires 2021-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC |
OBrien GeoffreyVice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · derivative · entry 3 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,000 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC |
OBrien GeoffreyVice President
|
Exercise / conversionCommon Stock | 11,318 | $2.46 | $27,842.28 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · nonDerivative · entry 2 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC |
OBrien GeoffreyVice President
|
Exercise / conversionCommon Stock | 32,000 | $2.54 | $81,280.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · nonDerivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.